XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Organization and Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2018
Accounting Policies [Abstract] |
Contract with Customer, Asset and Liability | The following table reflects the Company’s contract assets and contract liabilities:
| September 30, 2018 |  | December 31, 2017
| (In thousands)
Short-term unbilled receivables - included in accounts receivable and unbilled receivables | $ | 9,475 |  |  | $ | 4,590 |
Long-term unbilled receivables - included in other long-term assets | 15,573 |  |  | 9,475 |
Total contract assets | $ | 25,048 |  |  | $ | 14,065 |
Short-term deferred revenues | $ | 87,777 |  |  | $ | 78,774 |
Long-term deferred revenues | 10,634 |  |  | 10,623 |
Total contract liabilities | $ | 98,411 |  |  | $ | 89,397 |
Schedule of New Accounting Pronouncements and Changes in Accounting Principles | Adoption of the standard related to revenue recognition impacted the Company’s reported results as follows:
| Three months ended September 30, 2017
| As reported |  | Adjustment |  | As adjusted
| (In thousands)
Revenues |  |  |  |  |
Automation and Analytics | $ | 154,651 |  |  | $ | (34 | ) |  | $ | 154,617 |
Medication Adherence | 32,131 |  |  | — |  |  | 32,131 |
Gross profit |  |  |  |  |
Automation and Analytics | 74,911 |  |  | (34 | ) |  | 74,877 |
Medication Adherence | 9,942 |  |  | — |  |  | 9,942 |
Selling, general, and administrative expenses | 58,725 |  |  | (2,517 | ) |  | 56,208 |
Provision for income taxes | 751 |  |  | 966 |  |  | 1,717 |
Net income | $ | 6,231 |  |  | $ | 1,517 |  |  | $ | 7,748 |
Net income per share - basic | $ | 0.17 |  |  | $ | 0.04 |  |  | $ | 0.21 |
Net income per share - diluted | $ | 0.16 |  |  | $ | 0.04 |  |  | $ | 0.20 |
| Nine months ended September 30, 2017
| As reported |  | Adjustment |  | As adjusted
| (In thousands)
Revenues |  |  |  |  |
Automation and Analytics | $ | 427,249 |  |  | $ | (1,878 | ) |  | $ | 425,371 |
Medication Adherence | 90,972 |  |  | — |  |  | 90,972 |
Gross profit |  |  |  |  |
Automation and Analytics | 198,032 |  |  | (1,878 | ) |  | 196,154 |
Medication Adherence | 28,988 |  |  | — |  |  | 28,988 |
Selling, general, and administrative expenses | 186,818 |  |  | (6,748 | ) |  | 180,070 |
Provision for (benefit from) income taxes | (11,232 | ) |  | 1,891 |  |  | (9,341 | )
Net income (loss) | $ | (3,686 | ) |  | $ | 2,979 |  |  | $ | (707 | )
Net income (loss) per share - basic | $ | (0.10 | ) |  | $ | 0.08 |  |  | $ | (0.02 | )
Net income (loss) per share - diluted | $ | (0.10 | ) |  | $ | 0.08 |  |  | $ | (0.02 | )
| December 31, 2017
| As reported |  | Adjustment |  | As adjusted
| (In thousands)
Accounts receivable and unbilled receivables, net | $ | 189,227 |  |  | $ | 819 |  |  | $ | 190,046 |
Prepaid expenses | 36,060 |  |  | (15,668 | ) |  | 20,392 |
Prepaid commissions | — |  |  | 41,432 |  |  | 41,432 |
Other long-term assets | 39,841 |  |  | 9,475 |  |  | 49,316 |
Deferred revenues, net | 86,104 |  |  | (7,330 | ) |  | 78,774 |
Long-term, deferred revenues | 17,244 |  |  | (6,621 | ) |  | 10,623 |
Long-term, deferred tax liabilities | 28,579 |  |  | 12,867 |  |  | 41,446 |
Stockholders’ equity | 517,199 |  |  | 37,142 |  |  | 554,341 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contract balances and changes in contract balances. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e765-108305 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.10-01.(b)(6)) -URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e725-108305 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794 + Details
Name: | us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration